九典制药
(300705)
| 流通市值：64.99亿 | | | 总市值：87.93亿 |
| 流通股本：3.67亿 | | | 总股本：4.96亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 491,018,878.6 | 499,562,027.45 | 524,449,305.84 | 425,048,395.14 |
| 衍生金融资产 | 0 | 0 | 0 | 0 |
| 应收票据及应收账款 | 468,105,227.67 | 469,376,494.38 | 465,770,935.3 | 577,841,998.8 |
| 其中：应收票据 | 44,247,585.15 | 39,584,749.79 | 32,998,055.89 | 32,273,011.48 |
| 应收账款 | 423,857,642.52 | 429,791,744.59 | 432,772,879.41 | 545,568,987.32 |
| 应收款项融资 | 51,813,001.06 | 39,265,391.47 | 31,193,615.47 | 47,918,612.36 |
| 预付款项 | 27,281,706.92 | 17,153,140.65 | 15,673,161.48 | 13,000,066.96 |
| 其他应收款合计 | 6,431,296.16 | 4,482,211.41 | 5,207,443.44 | 3,718,646.05 |
| 其中:应收利息 | 0 | 0 | 0 | 0 |
| 应收股利 | 0 | 0 | 0 | 0 |
| 存货 | 333,214,211.48 | 320,032,659.35 | 304,720,472.89 | 265,529,133.3 |
| 合同资产 | 0 | 0 | 0 | 0 |
| 一年内到期的非流动资产 | 0 | 0 | 0 | 0 |
| 其他流动资产 | 692,283.73 | 12,061,580.3 | 5,650,443.3 | 6,610,093.87 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,597,576,477.66 | 1,512,734,633.76 | 1,483,571,928.4 | 1,429,958,213.6 |
| 非流动资产: | | | | |
| 债权投资 | 0 | 0 | 0 | 0 |
| 其他债权投资 | 0 | 0 | 0 | 0 |
| 长期应收款 | 0 | 0 | 0 | 0 |
| 长期股权投资 | 1,992,141.51 | 0 | 0 | 0 |
| 其他权益工具投资 | 86,405,000 | 86,405,000 | 30,000,000 | 30,000,000 |
| 其他非流动金融资产 | 0 | 0 | 0 | 0 |
| 投资性房地产 | 3,554,642.65 | 3,628,100.62 | 3,701,558.59 | 3,775,016.56 |
| 固定资产 | 1,165,382,449.64 | 1,165,405,018.43 | 1,079,246,180.49 | 1,071,497,306.31 |
| 在建工程 | 79,978,113.67 | 49,735,861.75 | 81,987,397.67 | 69,315,025.87 |
| 生产性生物资产 | 0 | 0 | 0 | 0 |
| 油气资产 | 0 | 0 | 0 | 0 |
| 使用权资产 | 77,283.29 | 103,044.38 | 128,805.47 | 154,566.56 |
| 无形资产 | 106,759,278.02 | 86,993,561.35 | 88,282,266.08 | 88,819,724.21 |
| 开发支出 | 30,162,915.78 | 26,676,639.59 | 24,822,254.94 | 23,412,547.28 |
| 商誉 | 0 | 0 | 0 | 0 |
| 长期待摊费用 | 3,997,144.98 | 4,280,208.29 | 4,500,437.03 | 4,279,595.72 |
| 递延所得税资产 | 52,939,233.02 | 51,725,529.03 | 59,617,537.67 | 66,294,812.67 |
| 其他非流动资产 | 111,851,735.31 | 79,819,330.14 | 102,418,792.1 | 83,693,001.11 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,643,099,937.87 | 1,554,772,293.58 | 1,474,705,230.04 | 1,441,241,596.29 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,240,676,415.53 | 3,067,506,927.34 | 2,958,277,158.44 | 2,871,199,809.89 |
| 流动负债: | | | | |
| 短期借款 | 29,028,625 | 36,035,819.44 | 42,046,184.72 | 51,847,264.16 |
| 交易性金融负债 | 0 | 0 | 0 | 0 |
| 衍生金融负债 | 0 | 0 | 0 | 0 |
| 应付票据及应付账款 | 150,143,858.93 | 155,050,609.02 | 122,721,492.38 | 159,294,977.79 |
| 其中：应付票据 | 31,728,178.55 | 7,394,899 | 0 | 23,619,014.28 |
| 应付账款 | 118,415,680.38 | 147,655,710.02 | 122,721,492.38 | 135,675,963.51 |
| 预收款项 | 0 | 0 | 0 | 0 |
| 合同负债 | 29,088,694.12 | 31,585,346.32 | 46,144,813.62 | 37,270,385.51 |
| 应付职工薪酬 | 31,636,138.56 | 31,797,968.27 | 28,992,381.02 | 46,607,359.64 |
| 应交税费 | 34,851,746.42 | 19,600,398.26 | 17,815,660.06 | 36,268,736.56 |
| 其他应付款合计 | 62,120,516.46 | 64,153,989.19 | 64,424,004.36 | 59,629,963.86 |
| 其中:应付利息 | 0 | 0 | 0 | 0 |
| 应付股利 | 0 | 0 | 0 | 0 |
| 一年内到期的非流动负债 | 6,136,267.33 | 10,793,666.72 | 6,502,869.58 | 6,063,751.52 |
| 其他流动负债 | 34,726,851.86 | 30,429,871.21 | 28,670,295.77 | 18,579,140.92 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 377,732,698.68 | 379,447,668.43 | 357,317,701.51 | 415,561,579.96 |
| 非流动负债: | | | | |
| 长期借款 | 88,000,000 | 81,889,541.15 | 66,451,952.4 | 58,830,636.97 |
| 应付债券 | 244,179,249.14 | 277,550,306.33 | 278,056,750.25 | 273,650,941.97 |
| 优先股 | 0 | 0 | 0 | 0 |
| 永续债 | 0 | 0 | 0 | 0 |
| 租赁负债 | 0 | 0 | 21,014.73 | 46,759.89 |
| 长期应付款 | 0 | 0 | 0 | 0 |
| 长期应付职工薪酬 | 0 | 0 | 0 | 0 |
| 预计负债 | 0 | 0 | 0 | 0 |
| 递延收益 | 143,184,354.82 | 145,639,380.91 | 145,269,051 | 145,374,403.2 |
| 递延所得税负债 | 4,576,148.92 | 4,703,345.12 | 4,338,612.18 | 4,465,588.36 |
| 其他非流动负债 | 0 | 0 | 0 | 0 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 479,939,752.88 | 509,782,573.51 | 494,137,380.56 | 482,368,330.39 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 857,672,451.56 | 889,230,241.94 | 851,455,082.07 | 897,929,910.35 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 489,629,635 | 486,526,829 | 345,148,416 | 345,145,427 |
| 其他权益工具 | 72,207,279.12 | 83,430,671.83 | 84,926,235.46 | 84,941,690.13 |
| 资本公积 | 467,077,986.66 | 419,704,332.79 | 537,893,809.06 | 529,901,790.25 |
| 减:库存股 | 0 | 0 | 0 | 0 |
| 其他综合收益 | 2,788,850 | 2,788,850 | 0 | 0 |
| 专项储备 | 306,138.03 | 436,219.8 | 1,039,190.13 | 1,136,039.56 |
| 盈余公积 | 124,462,975.51 | 124,462,975.51 | 124,462,975.51 | 124,462,975.51 |
| 未分配利润 | 1,226,531,099.65 | 1,060,926,806.47 | 1,013,351,450.21 | 887,681,977.09 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,383,003,963.97 | 2,178,276,685.4 | 2,106,822,076.37 | 1,973,269,899.54 |
| 少数股东权益 | 0 | 0 | 0 | 0 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,383,003,963.97 | 2,178,276,685.4 | 2,106,822,076.37 | 1,973,269,899.54 |
| 负债和股东权益合计 | 3,240,676,415.53 | 3,067,506,927.34 | 2,958,277,158.44 | 2,871,199,809.89 |
| 公告日期 | 2024-10-29 | 2024-08-24 | 2024-04-25 | 2024-04-25 |
| 审计意见(境内) | | | | 标准无保留意见 |